𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors

✍ Scribed by Thomas Kuhnt; Axel Becker; Marc Bloching; Johannes Schubert; Gunther Klautke; Rainer Fietkau; Juergen Dunst

Book ID
111641086
Publisher
Springer US
Year
2006
Tongue
English
Weight
314 KB
Volume
23
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hyperfractionated accelerated radiothera
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 267 KB πŸ‘ 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Neurotoxicity in a phase I trial of cont
Neurotoxicity in a phase I trial of continuous-infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer
✍ Gerald H. Clamon; Lynn Baatz; Henry T. Hoffman; David H. Hussey; Matthew Glascoc πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 569 KB

## Background: Both twice daily fractionated radiotherapy and concurrent cisplatin with once-daily radiotherapy have been shown to improve local disease control in patients with head and neck cancer. the objective of this phase i trial was to determine the maximum tolerated dose of cisplatin which